{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:03:51Z","timestamp":1775775831016,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>For breast cancer patients, postoperative lymphedema and upper limb movement disorders are serious complications that absolutely reduce their quality of life (QOL). To evaluate this serious complication, we used \u201cQuick Dash\u201d or \u201cFACT-B\u201d, which can assess a patient's physical, social, emotional, and functional health status. To evaluate their breast cancer surgery-related dysfunction correctly, \u201cFACT-B\u2009+\u20094\u201d was created by adding four questions about \u201carm swelling'' and \u201ctenderness\u201d. We have translated it into Japanese according to international translation guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>At the beginning, we contacted FACT headquarters that we would like to create a Japanese version of FACT-B\u2009+\u20094. They formed the FACIT Trans Team (FACIT) following international translation procedures, and then, we began translating according to them. The steps are 1: perform \u201cForward and Reverse translations\u201d to create a \u201cPreliminary Japanese version\u201d, 2: request the cooperation of 5 breast cancer patients and \u201cconduct a pilot study\u201d and \u201cquestionnaire survey\u201d, and 3: amendments and final approval based on pilot study results and clinical perspectives.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>In Step1, FACIT requested faithful translation of the words, verbs, and nouns from the original text. In Step2, patients reported that they felt uncomfortable with the Japanese version words such as \u201cnumb'' and \u201cstiffness'' and felt that it might be difficult to describe their symptoms accurately. In Step3, we readjusted the translation to be more concise and closer to common Japanese language, and performed \u201cStep1\u201d again to ensure that the translation definitely retained the meaning of the original.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A Japanese version of FACT has existed until now, but there was no Japanese version of FACT-B\u2009+\u20094, which adds four additional items to evaluate swelling and pain in the upper limbs. This time, we have created a Japanese version that has been approved by FACT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12282-025-01701-x","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:32:02Z","timestamp":1746700322000},"page":"773-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Japanese translation of the Functional Assessment of Cancer Therapy-Breast\u2009+\u20094 (FACT-B\u2009+\u20094) following international guidelines: a verification of linguistic validity"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-2332","authenticated-orcid":false,"given":"Takahiro","family":"Tsukioki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saya R.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Terata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguo","family":"Iwatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumikata","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"4","key":"1701_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejso.2014.12.006","volume":"41","author":"H Sackey","year":"2015","unstructured":"Sackey H, Johansson H, Sandelin K, Liljegren G, MacLean G, Frisell J, et al. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery. Eur J Surg Oncol. 2015;41(4):577\u201384.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1701_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-011-1614-z","volume":"130","author":"W Rief","year":"2011","unstructured":"Rief W, Bardwell WA, Dimsdale JE, Natarajan L, Flatt SW, Pierce JP. Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat. 2011;130(2):579\u201386.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1701_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1756-9966-27-32","volume":"27","author":"A Montazeri","year":"2008","unstructured":"Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27(1):32.","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"1701_CR4","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1200\/JCO.2002.09.018","volume":"20","author":"W Kwan","year":"2002","unstructured":"Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20(20):4242\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1701_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/A:1026564723698","volume":"64","author":"T Kuehn","year":"2000","unstructured":"Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, et al. Long-term morbidity following axillary dissection in breast cancer patients\u2013clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64(3):275\u201386.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1701_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","volume":"17","author":"TF Hack","year":"1999","unstructured":"Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999;17(1):143\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1701_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1701_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s12282-021-01263-8","volume":"28","author":"Y Lin","year":"2021","unstructured":"Lin Y, Xu Y, Wang C, Song Y, Huang X, Zhang X, et al. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis. Breast Cancer. 2021;28(6):1261\u201372.","journal-title":"Breast Cancer"},{"issue":"2","key":"1701_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111\u20138.","journal-title":"J Surg Oncol"},{"issue":"3","key":"1701_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American college of surgeons oncology group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264(3):413\u201320.","journal-title":"Ann Surg"},{"issue":"2","key":"1701_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10549-017-4423-1","volume":"166","author":"YJ Kang","year":"2017","unstructured":"Kang YJ, Han W, Park S, You JY, Yi HW, Park S, et al. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy. Breast Cancer Res Treat. 2017;166(2):473\u201380.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1701_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00595-017-1558-y","volume":"48","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y, Ikeda K, Watanabe C, Kamei Y, Tokunaga S, Tsuboguchi Y, et al. Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up. Surg Today. 2018;48(1):87\u201394.","journal-title":"Surg Today"},{"issue":"1","key":"1701_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s13063-018-3021-9","volume":"19","author":"G Henke","year":"2018","unstructured":"Henke G, Knauer M, Ribi K, Hayoz S, G\u00e9rard MA, Ruhstaller T, et al. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Trials. 2018;19(1):667.","journal-title":"Trials"},{"issue":"10","key":"1701_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1701_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382.","journal-title":"Ann Surg"},{"issue":"5","key":"1701_CR16","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","volume":"23","author":"EJ Diego","year":"2016","unstructured":"Diego EJ, McAuliffe PF, Soran A, McGuire KP, Johnson RR, Bonaventura M, et al. Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes. Ann Surg Oncol. 2016;23(5):1549\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1701_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","volume":"19","author":"I Natsiopoulos","year":"2019","unstructured":"Natsiopoulos I, Intzes S, Liappis T, Zarampoukas K, Zarampoukas T, Zacharopoulou V, et al. Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and Became cN0 after treatment. Clin Breast Cancer. 2019;19(3):208\u201315.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"1701_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","volume":"25","author":"C Siso","year":"2018","unstructured":"Siso C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O, et al. Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA Trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment. Ann Surg Oncol. 2018;25(3):784\u201391.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1701_CR19","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809\u201319.","journal-title":"Cancer"},{"issue":"3","key":"1701_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139.","journal-title":"J Clin Oncol"},{"issue":"6846","key":"1701_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM, O\u2019Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160\u20134.","journal-title":"BMJ"},{"issue":"1","key":"1701_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1753193407087121","volume":"33","author":"JJ Dias","year":"2008","unstructured":"Dias JJ, Rajan RA, Thompson JR. Which questionnaire is best? The reliability, validity and ease of use of the patient evaluation measure, the disabilities of the arm, shoulder and hand and the michigan hand outcome measure. J Hand Surg Eur. 2008;33(1):9\u201317.","journal-title":"J Hand Surg Eur"},{"issue":"3","key":"1701_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5152\/ejbh.2017.3522","volume":"13","author":"Y Bakar","year":"2017","unstructured":"Bakar Y, Tu\u011fral A, \u00d6zdemir \u00d6, Duygu E, \u00dcyet\u00fcrk \u00dc. Translation and validation of the Turkish version of lymphedema quality of life tool (LYMQOL) in patients with breast cancer related lymphedema. Eur J Breast Health. 2017;13(3):123\u20138.","journal-title":"Eur J Breast Health"},{"issue":"6","key":"1701_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11136-012-0261-0","volume":"22","author":"HA Huijer","year":"2013","unstructured":"Huijer HA, Sagherian K, Tamim H. Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon. Qual Life Res. 2013;22(6):1473\u201381.","journal-title":"Qual Life Res"},{"issue":"35","key":"1701_CR25","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1200\/JCO.22.02775","volume":"41","author":"DF Cella","year":"2023","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 2023;41(35):5335\u201344.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1701_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","volume":"15","author":"MJ Brady","year":"1997","unstructured":"Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;15(3):974\u201386.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1701_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1012278023233","volume":"68","author":"S Coster","year":"2001","unstructured":"Coster S, Poole K, Fallowfield LJ. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat. 2001;68(3):273\u201382.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-025-01701-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:44:53Z","timestamp":1750164293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-025-01701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s12282-025-01701-x","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kaori Terata has payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Astrazeneca, Lilly, Chugai, Pfizer, and Daiichisankyo. Other authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}